Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharmacol Exp Ther ; 314(3): 1079-86, 2005 Sep.
Article in English | MEDLINE | ID: mdl-15976018

ABSTRACT

Glucans are immunomodulatory carbohydrates found in the cell walls of fungi and certain bacteria. We examined the pharmacokinetics of three water-soluble glucans (glucan phosphate, laminarin, and scleroglucan) after oral administration of 1 mg/kg doses in rats. Maximum plasma concentrations for glucan phosphate occurred at 4 h. In contrast, laminarin and scleroglucan showed two plasma peaks between 0.5 and 12 h. At 24 h, 27 +/- 3% of the glucan phosphate and 20 +/- 7% of the laminarin remained in the serum. Scleroglucan was rapidly absorbed and eliminated. The liver did not significantly contribute to the clearance of plasma glucan. Biological effects were further studied in mice. Following oral administration of 1 mg, glucans were bound and internalized by intestinal epithelial cells and gut-associated lymphoid tissue (GALT) cells. Internalization of glucan by intestinal epithelial cells was not Dectin-dependent. GALT expression of Dectin-1 and toll-like receptor (TLR) 2, but not TLR4, increased following oral administration of glucan. Oral glucan increased systemic levels of interleukin (IL)-12 (151 +/- 15%) in mice. Oral glucan administration also increased survival in mice challenged with Staphylococcus aureus or Candida albicans. These data demonstrate that orally administered water-soluble glucans translocate from the gastrointestinal (GI) tract into the systemic circulation. The glucans are bound by GI epithelial and GALT cells, and they modulate the expression of pattern recognition receptors in the GALT, increase IL-12 expression, and induce protection against infectious challenge.


Subject(s)
Glucans/pharmacology , Immunity, Innate/drug effects , Intestinal Absorption , Administration, Oral , Animals , Biological Availability , Candidiasis/immunology , Cytokines/biosynthesis , Glucans/administration & dosage , Glucans/pharmacokinetics , Lectins, C-Type , Male , Membrane Proteins/analysis , Membrane Proteins/physiology , Mice , Mice, Inbred ICR , Nerve Tissue Proteins/analysis , Nerve Tissue Proteins/physiology , Peyer's Patches/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Immunologic/analysis , Staphylococcal Infections/immunology , Toll-Like Receptor 2
2.
Biotechnol Appl Biochem ; 41(Pt 1): 89-95, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15163313

ABSTRACT

Human mast-cell chymase (EC 3.4.21.39) is a chymotrypsin-like serine protease that is stored in and released from mast-cell granules. This enzyme has been expressed in Pichia pastoris by homologous recombination of the cDNA coding for the mature active chymase into the Pichia genome. Cells producing the highest levels of recombinant human chymase were selected by activity screening and they were grown in a fermentor. Methanol induction resulted in the secretion of active chymase into the Pichia growth media and increasing levels of enzyme were detected in the media for 5 days. Active enzyme was purified from the culture media with a 22% yield of activity by a simple two-step procedure involving hydrophobic-interaction chromatography followed by affinity chromatography on immobilized heparin. The major peak from the heparin column contained a single band of 30.6 kDa on SDS/PAGE. The purified recombinant human chymase was 96% active and the yield was 2.2 mg/l of growth media.


Subject(s)
Cell Culture Techniques/methods , Cloning, Molecular/methods , Mast Cells/enzymology , Pichia/enzymology , Protein Engineering/methods , Serine Endopeptidases/biosynthesis , Serine Endopeptidases/chemistry , Chymases , Enzyme Activation , Enzyme Stability , Gene Expression Regulation, Fungal/physiology , Genetic Enhancement/methods , Humans , Molecular Weight , Pichia/genetics , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Serine Endopeptidases/genetics , Serine Endopeptidases/isolation & purification
3.
Int Immunopharmacol ; 4(9): 1209-15, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15251116

ABSTRACT

Glucans are microbial cell wall carbohydrates that are shed into the circulation of patients with infections. Glucans are immunomodulatory and have structures that are influenced by bacterial or fungal species and growth conditions. We developed a method to covalently label carbohydrates with a fluorophore on the reducing terminus, and used the method to study the pharmacokinetics following intravenous administration of three highly purified and characterized glucans (glucan phosphate, laminarin and scleroglucan) that varied according to molecular size, branching frequency and solution conformation. Elimination half-life was longer (3.8+/-0.8 vs. 2.6+/-0.2 and 3.1+/-0.6 h) and volume of distribution lower (350+/-88 ml/kg vs. 540+/-146 and 612+/-154 ml/kg) for glucan phosphate than for laminarin and scleroglucan. Clearance was lower for glucan phosphate (42+/-6 ml/kg h) than for laminarin (103+/-17 ml/kg h) and scleroglucan (117+/-19 ml/kg h). Since plasma levels at steady state are inversely related to clearance, these differences suggest that pharmacokinetics could favor higher blood levels of glucans with certain physicochemical properties.


Subject(s)
beta-Glucans/pharmacokinetics , Animals , Area Under Curve , Glucans/administration & dosage , Glucans/chemistry , Glucans/pharmacokinetics , Half-Life , Injections, Intravenous , Limulus Test , Linear Models , Male , Polysaccharides/administration & dosage , Polysaccharides/chemistry , Polysaccharides/pharmacokinetics , Rats , Rats, Sprague-Dawley , beta-Glucans/administration & dosage , beta-Glucans/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...